Please complete the CAPTCHA to continue
@alavabp.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mark Backer is listed as General Manager at Alava Biopharm Partners at Stanford University School of Medicine, based in San Mateo, California, United States. AeroLeads shows a work email signal at alavabp.com and a matched LinkedIn profile for Mark Backer.
Mark Backer previously worked as General Manager at Alava Biopharm Partners and Industry advisor to SPARK program at Stanford University School Of Medicine. Mark Backer holds Ph.D, Chemical Engineering from University Of Washington.
This section adds company-level context without repeating Mark Backer's masked contact details.
AeroLeads found 1 current-domain work email signal for Mark Backer. Compare company email patterns before reaching out.
Experienced, versatile executive with deep expertise and a record of success in developing biological products from applied research through licensure (7 approved products over 25+ years). Currently managing Alava Biopharm Partners, a consulting firm providing CMC, Regulatory and Nonclinical Development consulting for biologicals and small molecules. Check our website at www.alavabp.com!Core technical experience in cell culture and fermentation, process development, scaleup and tech transfer, management of outsourced development and manufacturing.Business experience as a CEO, board member and advisor to biotech firms and investors.Industry advisor to Stanford Medical School SPARK programProducts:• 13 years vaccine development and manufacturing experience • Antibodies and recombinant proteins • Cell and gene therapies
Listed skills include Biotechnology, Technology Transfer, Vaccines, Biopharmaceuticals, and 27 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
The team at Alava Biopharm Partners LLC provides consulting and contracting services for product developers and investors. In 2014, Alava expanded from its initial focus on CMC activities, adding Regulatory Affairs and Nonclinical Development consulting. Please check our website and team members at www.alavabp.com!
Responsible for CMC activities including Technical Development, Manufacturing and Quality functions.
Developing oral vaccine products based on a nonreplicating vector and novel adjuvant. Raised Series A financing. Formerly known as West Coast Biologicals.
Us
Founding Chairman, 2001-04. Board member through May, 2007. Company was purchased by Sigma (SAFC Pharma). The company provides contract manufacturing and filling services for viral-based vectors and vaccines.
Us
Developed a portfolio of antibodies for cancer and autoimmune diseases. Led over 100 staff including process, analytical and formulation development teams, and engineering/production support group.
Gaithersburg, Maryland, Us
Led process/formulation development and commercial production support teams through filing of FluMist BLA, development of refrigerator-stable FluMist format currently on market, and clinical manufacturing through Phase II.
Directed outsourced development and production activities, including overseas antibody manufacture at 10kL scale. Acquired by Corixa and then GSK.
Pioneering stem cell technology for hematologic cancers and gene therapy; developed ex vivo culture approach for human stem cells. Acquired by Novartis.
Early stage development and manufacturing of Rituxan, prior to the company's relocation to La Jolla.
Indianapolis, Indiana, Us
Initiated the company's cell culture development efforts, with operations at 1300-L scale.
Seventh employee of Genentech. Worked as RA on cloning of insulin and growth hormone, set up pilot plant, and produced the world's first recombinant products at 600-L scale.
Quick answers generated from the profile data available on this page.
Mark Backer works for Stanford University School of Medicine.
Mark Backer is listed as General Manager at Alava Biopharm Partners at Stanford University School of Medicine.
AeroLeads has found 1 work email signal at @alavabp.com for Mark Backer at Stanford University School of Medicine.
Mark Backer is based in San Mateo, California, United States while working with Stanford University School of Medicine.
Mark Backer has worked for Alava Biopharm Partners, Stanford University School Of Medicine, Jennerex Biotherapeutics, Vaxart, Inc., and Molecular Medicine Bioservices.
You can use AeroLeads to view verified contact signals for Mark Backer at Stanford University School of Medicine, including work email, phone, and LinkedIn data when available.
Mark Backer holds Ph.D, Chemical Engineering from University Of Washington.
Mark Backer is listed with skills including Biotechnology, Technology Transfer, Vaccines, Biopharmaceuticals, Cell Culture, Gmp, Manufacturing, and Antibodies.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts